Mesogen Inc. out of The Woodlands, Texas, has developed a transplantable Retinal Pigmented Epithelium (RPE) patch to cure ...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and ...

The DISCOVER Phase 1/2a trial is an open-label, single ascending dose, 9-month study that will evaluate the safety and bioactivity of AXT107 ...

Shares of EyePoint Pharmaceuticals dropped nearly 30% premarket on Monday after the company said its experimental eye disease ...

Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study ...

EyePoint (EYPT) stock tumbled nearly 30% in premarket trading Monday after the company said a Phase 2 study for its eye drug ...

A recent study found home-monitoring tests as a potential solution to reduce the burden of neovascular age-related macular ...

A couple of beers after work or a half-bottle of wine at dinner is a beloved Aussie tradition, but new findings from a ...

“Sight Beyond Limits”: On display through May. The Mandelbaum and Ambert Family Vision Gallery is located on the 9th floor, ...

Spirulina and chlorella are types of microalgae commonly taken in supplement form. They share some benefits, but they each offer unique properties.

Targeting a major pharmaceutical market in retinal diseases, EyePoint Pharmaceuticals has revealed that its lead drug ...